Cargando…
Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson’s Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies
A pharmacophore-based virtual screening methodology was used to discover new catechol-O-methyltransferase (COMT) inhibitors with interest in Parkinson’s disease therapy. To do so, pharmacophore models were constructed using the structure of known inhibitors and then they were used in a screening in...
Autores principales: | Cruz-Vicente, Pedro, Gonçalves, Ana M., Ferreira, Octávio, Queiroz, João A., Silvestre, Samuel, Passarinha, Luís A., Gallardo, Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780549/ https://www.ncbi.nlm.nih.gov/pubmed/35056108 http://dx.doi.org/10.3390/ph15010051 |
Ejemplares similares
-
Advances in Membrane-Bound Catechol-O-Methyltransferase Stability Achieved Using a New Ionic Liquid-Based Storage Formulation
por: Gonçalves, Ana M., et al.
Publicado: (2022) -
An artificial neural network for membrane-bound catechol-O-methyltransferase biosynthesis with Pichia pastoris methanol-induced cultures
por: Pedro, Augusto Q, et al.
Publicado: (2015) -
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol-O-Methyltransferase
por: Gonçalves, Ana M., et al.
Publicado: (2022) -
Development of fed-batch profiles for efficient biosynthesis of catechol-O-methyltransferase
por: Espírito Santo, G.M., et al.
Publicado: (2014) -
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
por: Cruz-Vicente, Pedro, et al.
Publicado: (2021)